Briefly, the N‐terminus of PTX3 was suggested to inhibit angiogenesis and tumour growth in fibroblast growth factor (FGF)‐dependent murine prostate cancer and melanoma by binding to fibroblast growth factors, including FGF2 and FGF8b.28, 29. This evidence concerns the gene PTX3 and prostate carcinoma.